Scheithauer Bernd W, Santi Mariarita, Richter Eric R, Belman Barry, Rushing Elisabeth J
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Hum Pathol. 2008 Nov;39(11):1708-12. doi: 10.1016/j.humpath.2008.02.019. Epub 2008 Jul 24.
As an initial manifestation of neurofibromatosis type 1, isolated neurofibroma of the urinary bladder occurs only rarely in the first 2 decades of life. We report a case of a 6-year-old African-American girl who presented in this manner and was found to have a plexiform neurofibroma as well as diffuse ganglioneuromatosis of the urinary bladder. We describe the clinical presentation, diagnostic procedures, and pathologic features encountered. In addition, we review the literature with respect to etiology, current treatment strategies, and the issue of surveillance for this complex lesion occurring in the pediatric population. Neurofibroma of the bladder should be considered in the differential diagnosis of painless hematuria in childhood. Its presentation in such patients warrants a complete evaluation to establish the diagnosis of neurofibromatosis type 1 and begin long-term surveillance for its associated manifestations. At present, there are no established criteria for the treatment of this rare lesion.
作为1型神经纤维瘤病的初始表现,孤立性膀胱神经纤维瘤在生命的前20年中很少出现。我们报告了一例6岁非裔美国女孩,她以这种方式就诊,被发现患有丛状神经纤维瘤以及膀胱弥漫性神经节神经瘤病。我们描述了临床表现、诊断程序和所遇到的病理特征。此外,我们回顾了关于病因、当前治疗策略以及儿科人群中这种复杂病变的监测问题的文献。膀胱神经纤维瘤应纳入儿童无痛性血尿的鉴别诊断。其在这类患者中的表现需要进行全面评估,以确立1型神经纤维瘤病的诊断,并开始对其相关表现进行长期监测。目前,对于这种罕见病变尚无既定的治疗标准。